- Impact of immunosuppression on the development of Epstein-Barr virus (EBV) viremia after pediatric liver transplantationB R Lu
Pediatric Gastroenterology, Hepatology, and Nutrition, Lucile Packard Children s Hospital, Stanford University Medical Center, Palo Alto, California, USA
Transplant Proc 45:301-4. 2013..Pediatric liver transplant (OLT) patients are at risk of posttransplant lymphoproliferative disease (PTLD) from Epstein-Barr virus (EBV). This study examined the impact of induction and immunosuppression on EBV viremia...